1.
|
A JemalF BrayMM CenterJ FerlayE WardD
FormanGlobal cancer statisticsCA Cancer J
Clin616990201110.3322/caac.20107
|
2.
|
E ScosyrevK NoyesC FengE MessingSex and
racial differences in bladder cancer presentation and mortality in
the USCancer1156874200910.1002/cncr.2398619072984
|
3.
|
H MiyamotoY ZhengK IzumiNuclear hormone
receptor signals as new therapeutic targets for urothelial
carcinomaCurr Cancer Drug
Targets121422201210.2174/15680091279888896522111835
|
4.
|
SS ShenCL SmithJ-T HsiehExpression of
estrogen receptors-α and -β in bladder cancer cell lines and human
bladder tumor tissueCancer106261026162006
|
5.
|
H MiyamotoZ YangY-T ChenPromotion of
bladder cancer development and progression by androgen receptor
signalsJ Natl Cancer
Inst99558568200710.1093/jnci/djk11317406000
|
6.
|
G SonpavdeN OkunoH WeissEfficacy of
selective estrogen receptor modulators in nude mice bearing human
transitional cell
carcinomaUrology6912211226200710.1016/j.urology.2007.02.04117572228
|
7.
|
AM JohnsonMJ O’ConnellH MiyamotoJ HuangJL
YaoEM MessingJE ReederAndrogenic dependence of exophytic tumor
growth in a transgenic mouse model of bladder cancer: a role for
thrombospodin-1BMC Urol87200810.1186/1471-2490-8-718433501
|
8.
|
J TengZ-Y WangDF JarrardDE BjorlingRoles
of estrogen receptor α and β in modulating urothelial cell
proliferationEndocr Relat Cancer153513642008
|
9.
|
SA BoorjianHV HeemersI FrankSA FarmerLJ
SchmidtTJ SeboDJ TindallExpression and significance of androgen
receptor coactivators in urothelial carcinoma of the bladderEndocr
Relat Cancer16123137200910.1677/ERC-08-012418845648
|
10.
|
C TuygunD KankayaA ImamogluA SertcelikK
ZenginM OktayN SertcelikSex-specific hormone receptors in
urothelial carcinomas of the human urinary bladder: a comparative
analysis of clinicopathological features and survival outcomes
according to receptor expressionUrol
Oncol294351201110.1016/j.urolonc.2009.01.033
|
11.
|
K IzumiY ZhengJ-W HsuC ChangH
MiyamotoAndrogen receptor signals regulate
UDP-glucuronosyltransferases in the urinary bladder: a potential
mechanism of androgen-induced bladder carcinogenesisMol
CarcinogenNov152011(Epub ahead of print)10.1002/mc.21833
|
12.
|
H MiyamotoJL YaoA ChauxExpression of
androgen and oestrogen receptors and its prognostic significance in
urothelial neoplasm of the urinary bladderBJU
Int10917161726201210.1111/j.1464-410X.2011.10706.x22221549
|
13.
|
Y LiK IzumiH MiyamotoThe role of the
androgen receptor in the development and progression of bladder
cancerJpn J Clin Oncol42569577201210.1093/jjco/hys07222593639
|
14.
|
DE NealL SharplesK SmithJ FennellyRR
HallAL HarrisThe epidermal growth factor receptor and the prognosis
of bladder
cancerCancer6516191625199010.1002/1097-0142(19900401)65:7%3C1619::AID-CNCR2820650728%3E3.0.CO;2-Q2311071
|
15.
|
H MiyamotoY KubotaS Noguchic-erbB-2
gene amplification as a prognostic marker in human bladder
cancerUrology556796832000
|
16.
|
Z LatifHER2/neu gene amplification and
protein overexpression in G3 pT2 transitional cell carcinoma of the
bladder: a role for anti-HER2 therapy?Eur J
Cancer405663200410.1016/j.ejca.2003.08.02714687790
|
17.
|
J BellmuntM HussainCP DinneyNovel
approaches with targeted therapies in bladder cancerCrit Rev Oncol
Hematol4685104200310.1016/S1040-8428(03)00067-2
|
18.
|
PC BlackPK AgarwalCPN DinneyTargeted
therapies in bladder cancer - an updateUrol
Oncol25433438200710.1016/j.urolonc.2007.05.01117826665
|
19.
|
NJ MacLaineMD WoodJC HolderRW ReesJ
SouthgateSensitivity of normal, paramalignant and malignant human
urothelial cells to inhibitors of the epidermal growth factor
receptor signaling pathwayMol Cancer
Res65363200810.1158/1541-7786.MCR-07-013418234962
|
20.
|
Z CuligA HobischMV CronauerAndrogen
receptor activation in prostatic tumor cell lines by insulin-like
growth factor-I, keratinocyte growth factor and epidermal growth
factorCancer Res54547454781994
|
21.
|
CW GregoryX FeiLA PongutaB HeHM BillFS
FrenchEM WilsonEpidermal growth factor increases coactivation of
the androgen receptor in recurrent prostate cancerJ Biol
Chem27971197130200410.1074/jbc.M30764920014662770
|
22.
|
IK MellinghoffI VivancoA KwonC TranJ
WongvipatCL SawyersHER2/neu kinase-dependent modulation of androgen
receptor function through effects on DNA binding and
stabilityCancer
Cell6517527200410.1016/j.ccr.2004.09.03115542435
|
23.
|
B MukherjeeD MayerDihydrotestosterone
interacts with EGFR/MAPK signaling and modulates EGFR levels in
androgen receptor-positive LNCaP prostate cancer cellsInt J
Oncol33623629200818695894
|
24.
|
J-C PignonB KoopmanschG NolensL DelacroixD
WaltregnyR WinklerAndrogen receptor controls EGFR and ERBB2 gene
expression at different levels in prostate cancer cell linesCancer
Res6929412949200910.1158/0008-5472.CAN-08-376019318561
|
25.
|
A MigliaccioG CastoriaMP GiovannelliF
AuricchioCross talk between epidermal growth factor (EGF) receptor
and extra nuclear steroid receptors in cell linesMol Cell
Endocrinol3271924201010.1016/j.mce.2010.06.01420603181
|
26.
|
Y ZhengK IzumiJL YaoH
MiyamotoDihydrotestosterone upregulates the expression of epidermal
growth factor receptor and ERBB2 in androgen receptor-positive
bladder cancer cellsEndocr Relat
Cancer18451464201110.1530/ERC-11-0010
|
27.
|
AM CanacciK IzumiY ZhengJ GordetskyJL YaoH
MiyamotoExpression of semenogelins I and II and its prognostic
significance in human prostate
cancerProstate7111081114201110.1002/pros.2132321557275
|
28.
|
A MigliaccioM Di DomenicoG CastoriaSteroid
receptor regulation of epidermal growth factor signaling through
Src in breast and prostate cancer cells: steroid antagonist
actionCancer Res651058510593200510.1158/0008-5472.CAN-05-0912
|
29.
|
Z GuoB DaiT JiangRegulation of androgen
receptor activity by tyrosine phosphorylationCancer
Cell10309319200610.1016/j.ccr.2006.08.02117045208
|
30.
|
C CaiDC PortnoyH WangX JiangS ChenSP
BalkAndrogen receptor expression in prostate cancer cells is
suppressed by activation of epidermal growth factor receptor and
ErbB2Cancer
Res6952025209200910.1158/0008-5472.CAN-09-002619491261
|
31.
|
P HenttuP VihkoGrowth factor regulation of
gene expression in the human prostatic carcinoma cell line
LNCaPCancer Res531051105819937679946
|